Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Nanomedicine‐boosting icaritin-based immunotherapy of advanced hepatocellular carcinoma
Yi Lu, Yue Gao, Huan Yang, et al.
Military Medical Research (2022) Vol. 9, Iss. 1
Open Access | Times Cited: 36

Showing 1-25 of 36 citing articles:

Multidisciplinary strategies to enhance therapeutic effects of flavonoids from Epimedii Folium: Integration of herbal medicine, enzyme engineering, and nanotechnology
Yi Lu, Qiulan Luo, Xiaobin Jia, et al.
Journal of Pharmaceutical Analysis (2022) Vol. 13, Iss. 3, pp. 239-254
Open Access | Times Cited: 100
Immune checkpoint inhibition mediated with liposomal nanomedicine for cancer therapy
Guanglong Ma, Weifeng Lin
Military Medical Research (2023) Vol. 10, Iss. 1
Open Access | Times Cited: 37
Cell membrane-camouflaged bufalin targets NOD2 and overcomes multidrug resistance in pancreatic cancer
Wei Zhang, Yibao Fan, Jinze Zhang, et al.
Drug Resistance Updates (2023) Vol. 71, pp. 101005-101005
Open Access | Times Cited: 30
Smart and bioinspired systems for overcoming biological barriers and enhancing disease theranostics
Xin Li, Yue Gao, Helin Li, et al.
Progress in Materials Science (2023) Vol. 140, pp. 101170-101170
Closed Access | Times Cited: 29
The role of circular RNAs in regulating resistance to cancer immunotherapy: mechanisms and implications
Yu Ma, Ting Wang, Xudong Zhang, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 5
Open Access | Times Cited: 15
Theranostics: a multifaceted approach utilizing nano-biomaterials
Mohammad Yasir, Ratnakar Mishra, Alok Shiomurti Tripathi, et al.
Discover Nano (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 13
Traditional Chinese medicine for the treatment of cancers of hepatobiliary system: from clinical evidence to drug discovery
Junyu Wu, Guping Tang, Chien‐shan Cheng, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 7
Promoting osteogenesis and bone regeneration employing icariin-loaded nanoplatforms
Mahsa Mohammadzadeh, Masoud Zarei, Hossein Abbasi, et al.
Journal of Biological Engineering (2024) Vol. 18, Iss. 1
Open Access | Times Cited: 6
Icaritin Derivative IC2 Induces Cytoprotective Autophagy of Breast Cancer Cells via SCD1 Inhibition
Yixuan Wang, Yi-Yuan Jin, Jie Wang, et al.
Molecules (2023) Vol. 28, Iss. 3, pp. 1109-1109
Open Access | Times Cited: 13
Progress and application of intelligent nanomedicine in urinary system tumors
Yingming Xiao, Lei Zhong, Jinpeng Liu, et al.
Journal of Pharmaceutical Analysis (2024) Vol. 14, Iss. 12, pp. 100964-100964
Open Access | Times Cited: 5
PD-L2 drives resistance to EGFR-TKIs: dynamic changes of the tumor immune environment and targeted therapy
Simeng Wang, Dongliang Su, Han Chen, et al.
Cell Death and Differentiation (2024) Vol. 31, Iss. 9, pp. 1140-1156
Closed Access | Times Cited: 5
A large-scale transcriptional analysis reveals herb-derived ginsenoside F2 suppressing hepatocellular carcinoma via inhibiting STAT3
Xue Tan, Xiaofang Ma, Yifei Dai, et al.
Phytomedicine (2023) Vol. 120, pp. 155031-155031
Closed Access | Times Cited: 12
Elevated FBXL6 activates both wild-type KRAS and mutant KRASG12D and drives HCC tumorigenesis via the ERK/mTOR/PRELID2/ROS axis in mice
Haojun Xiong, Hongqiang Yu, Jie Zhang, et al.
Military Medical Research (2023) Vol. 10, Iss. 1
Open Access | Times Cited: 12
SKA3 targeted therapies in cancer precision surgery: bridging bench discoveries to clinical applications – review article
Dechao Feng, Jie Wang, Yuhan Xiao, et al.
International Journal of Surgery (2024) Vol. 110, Iss. 4, pp. 2323-2337
Open Access | Times Cited: 4
Reshaping the immune microenvironment and reversing immunosenescence by natural products: prospects for immunotherapy in gastric cancer
Zhipeng Cao, Zhilin Wang, Yang Li, et al.
Seminars in Cancer Biology (2025) Vol. 110, pp. 1-16
Closed Access
Bibliometric analysis of nanomaterials in hepatocellular carcinoma treatment: research trends, knowledge structures, and emerging insights (2000–2024)
Xu Hou, Xiaohong Jiang, Wei Zhang, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Epimedii Folium flavonoids: A double-edged sword effect on the liver, a dual exploration of efficacy and toxicity
Meijun Yue, Yanlu Liu, Xiaoyu Feng, et al.
Journal of Pharmaceutical Analysis (2025), pp. 101269-101269
Open Access
Metabolic Engineering of Yarrowia lipolytica for Enhanced De Novo Biosynthesis of Icaritin
Weibo Sun, Xin Wang, Meng-Yu Fu, et al.
ACS Synthetic Biology (2025)
Closed Access
Multidimensional profiling of functionalized photothermal nanoplatforms for synergistic cancer immunotherapy: Design, strategy, and challenge
Wei Xiao, Mingzhu Song, Guanghao Jin, et al.
Coordination Chemistry Reviews (2023) Vol. 499, pp. 215488-215488
Closed Access | Times Cited: 9
Comparing the pharmacological effects of the prepared folium of Epimedium brevicornu Maxim. and Epimedium sagittatum Maxim. on kidney-Yang deficiency syndrome and liver injury complications
Xinyu Zheng, Senjie Li, Kai Wang, et al.
Fitoterapia (2024) Vol. 176, pp. 106006-106006
Closed Access | Times Cited: 3
Hyaluronic acid-modified liposomes Potentiated in-vivo anti-hepatocellular carcinoma of icaritin
Xiaoduan Sun, Zhenzhen He, Ruilin Lu, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 3
Icaritin Exerts Anti-Cancer Effects through Modulating Pyroptosis and Immune Activities in Hepatocellular Carcinoma
Yuanyuan Jiao, Wenqian Li, Wen Yang, et al.
Biomedicines (2024) Vol. 12, Iss. 8, pp. 1917-1917
Open Access | Times Cited: 3
Mitochondria-Targeted Icaritin Nanoparticles Induce Immunogenic Cell Death in Hepatocellular Carcinoma
Siyu Chen, Yiyang Sun, Yangla Xie, et al.
ACS Applied Materials & Interfaces (2024)
Closed Access | Times Cited: 3
Efficient production of icariin and baohuoside I from Epimedium Folium flavonoids by fungal α-l-rhamnosidase hydrolysing regioselectively the terminal rhamnose of epimedin C
Shanshan Zhang, Changning Lu, Shiping Cao, et al.
Biotechnology for Biofuels and Bioproducts (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 8
Purification and immobilization of β-glucosidase using surface modified mesoporous silica Santa Barbara Amorphous 15 for eco-friendly preparation of sagittatoside A
Ya-Ya Yang, Shunli Jing, Jiali Shao, et al.
Natural Products and Bioprospecting (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top